USP <62> Tests for Specified Microorganisms
GPTKB entity
Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
pharmacopeial standard
|
| gptkbp:appliesTo |
pharmaceutical products
|
| gptkbp:describes |
methods for detecting specified microorganisms
|
| gptkbp:firstPublished |
2007
|
| gptkbp:focusesOn |
microbiological examination
|
| https://www.w3.org/2000/01/rdf-schema#label |
USP <62> Tests for Specified Microorganisms
|
| gptkbp:partOf |
gptkb:United_States_Pharmacopeia_(USP)
|
| gptkbp:publishedBy |
gptkb:United_States_Pharmacopeial_Convention
|
| gptkbp:regulates |
acceptable limits for specified microorganisms
|
| gptkbp:relatedTo |
USP <61> Microbiological Examination of Nonsterile Products: Microbial Enumeration Tests
|
| gptkbp:specifies |
test procedures for Candida albicans
test procedures for Clostridia test procedures for Escherichia coli test procedures for Pseudomonas aeruginosa test procedures for Salmonella species test procedures for Staphylococcus aureus test procedures for bile-tolerant Gram-negative bacteria |
| gptkbp:updated |
USP 43-NF 38
|
| gptkbp:usedBy |
pharmaceutical manufacturers
microbiology laboratories |
| gptkbp:usedIn |
quality control
|
| gptkbp:bfsParent |
gptkb:USP_Microbiology_Standards
|
| gptkbp:bfsLayer |
7
|